Stock listing

LSE:OBI Ondine Biomedical, Inc. Share Price

Home listing (LSE) of Ondine Biomedical, Inc.

Follow Ondine Biomedical, Inc. into a list and get an email when it puts out news.

Share price · LSE:OBI

9.75p GBX (pence) 0.00 (0.0%)

Close on Oct 30, 2026

Past year -27.8% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
9.50p – 9.75p GBX (pence)Oct 30, 2026
Volume
195,218 sharesOct 30, 2026
Market cap
£64.47M GBPAt the close on Oct 30, 2026 · price × 661.2M shares outstanding
52-week range
7.50p – 15.50p GBX (pence)Lowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
£56,346 GBPMedian day 243,757 shares · 13 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Ondine Biomedical, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:OBI · Home9.75p GBX (pence)0.00 (0.0%)195,2189.625p9.75p9.50p9.75pClose on Oct 30, 2026
Frankfurt:VF5€0.091 EUR-0.001 (-0.5%)—€0.091€0.091€0.091€0.092Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · LSE:OBI · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
9.75p0.000.0%9.625p9.75p9.50p195,218
9.75p+0.25+2.6%10.00p10.00p9.675p186,077
9.50p0.000.0%9.60p10.00p9.50p150,057
9.50p-0.25-2.6%9.75p10.00p9.50p782,575
9.75p0.000.0%9.875p10.00p9.61p216,686
9.75p-0.50-4.9%10.00p10.00p9.50p317,214
10.25p0.000.0%10.25p10.50p10.00p220,750
10.25p0.000.0%10.25p10.25p10.00p242,985
10.25p+0.50+5.1%10.25p10.50p10.00p1,312,803
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p0
9.75p0.000.0%9.75p9.75p9.75p747,590
9.75p0.000.0%9.75p10.00p9.50p747,590
9.75p-0.25-2.5%10.25p10.50p9.50p305,756
10.00p-0.30-2.9%10.25p10.50p10.00p70,198
10.30p-0.45-4.2%10.75p11.00p9.60p1,686,327
10.75p0.000.0%10.75p11.00p10.49p534,220
10.75p0.000.0%10.75p11.00p10.49p475,805
10.75p0.000.0%10.50p11.00p10.00p217,632
10.75p+0.45+4.4%10.25p10.93p10.20p529,512
10.30p-0.20-1.9%10.50p11.00p10.12p1,885,428
10.50p-0.25-2.3%10.75p11.00p10.00p103,599
10.75p+0.50+4.9%10.50p11.00p10.00p883,474
10.25p-0.05-0.5%10.25p10.50p9.99p345,075
10.30p-0.95-8.4%11.25p11.50p10.06p1,384,879
11.25p+0.25+2.3%11.75p12.00p11.00p479,705
11.00p-0.25-2.2%11.25p11.50p11.00p46,748
11.25p0.000.0%11.25p11.50p11.00p595,590
11.25p0.000.0%11.25p11.50p11.00p808,687
11.25p-0.25-2.2%11.25p11.50p11.08p493,916
11.50p0.000.0%11.50p11.50p11.00p1,057,334
11.50p-0.50-4.2%12.15p12.30p11.50p2,484,474
12.00p+0.25+2.1%12.50p14.00p12.00p5,679,983
11.75p+0.55+4.9%11.75p12.00p11.59p818,973
11.20p-0.30-2.6%11.75p12.00p11.20p305,285
11.50p-0.25-2.1%11.75p12.00p11.50p424,927
11.75p-0.50-4.1%12.25p12.50p11.50p371,594
12.25p-0.25-2.0%12.25p12.50p12.00p244,528
12.50p+0.25+2.0%12.25p12.50p12.00p78,758
12.25p0.000.0%12.25p12.25p12.00p56,253
12.25p-0.75-5.8%12.25p12.50p11.85p395,761
13.00p+0.90+7.4%12.50p13.00p12.00p96,768
12.10p-1.65-12.0%13.75p14.00p12.00p1,671,264
13.75p0.000.0%13.75p13.75p13.50p4,491
13.75p0.000.0%13.75p14.00p13.50p110,427
13.75p0.000.0%13.75p14.00p13.50p69,620
13.75p0.000.0%13.75p14.00p13.55p564,196
13.75p+0.25+1.9%13.68p14.00p13.68p134,284
13.50p+0.50+3.8%13.00p13.50p13.00p528,821
13.00p0.000.0%13.00p13.50p12.85p106,077
13.00p0.000.0%13.00p13.50p12.76p165,628
13.00p0.000.0%13.00p13.50p13.00p408,057
13.00p-0.25-1.9%13.25p13.50p12.75p317,837
13.25p-0.50-3.6%13.75p14.00p13.05p689,745
13.75p0.000.0%14.00p14.50p13.50p198,507
Ticker
LSE:OBI
Asset type
Stock
Exchange
LSE
Currency
GBX

What changed lately

Calls

Replays

  • Ondine Biomedical (LSE:OBI) — Investor Presentation of Phase 3 Topline Results

    Thu, Sep 10, 2026 · 11:30 AM ET

    Watch Transcript

  • Ondine Biomedical (LSE:OBI) — Results for the year ended 31 December 2025

    Thu, Jun 04, 2026 · 11:30 AM ET

    Watch Transcript

  • Ondine Biomedical (LSE:OBI) — Interim financial results for the period ended 30 June 2025

    Fri, Sep 26, 2025 · 11:30 AM ET

    Watch Transcript

Latest news

LANTERN Safety Results Presented at IDWeek

Oct 28, 2026

Closed 9.50p (0.0%) on Oct 28, 2026

Holding(s) in Company

Oct 26, 2026

Closed 9.50p (-2.6%) on Oct 27, 2026

Ottawa Heart Institute Reduces CABG SSIs by 51.5%

Oct 23, 2026

Closed 9.75p (-4.9%) on Oct 23, 2026

Capital Access Window - Ondine Biomedical Inc

Oct 20, 2026

Closed 10.25p (+5.1%) on Oct 20, 2026

Result of Fundraise, Restoration of Trading & TVR

Oct 20, 2026

Closed 10.25p (+5.1%) on Oct 20, 2026

Proposed c.£10m (C$18.88m) Fundraise

Oct 19, 2026

Closed 10.25p (+5.1%) on Oct 20, 2026

Capital Access Window

Sep 30, 2026

Closed 9.75p (0.0%) on Sep 30, 2026

2026 Interim Results & Post-Period Momentum

Sep 30, 2026

Closed 9.75p (0.0%) on Sep 30, 2026

Ondine and Mela Advance NHS ICU Market Access

Sep 29, 2026

Closed 9.75p (0.0%) on Sep 29, 2026

Steriwave Deploys in 5 Southern Ontario Hospitals

Sep 23, 2026

Closed 10.75p (0.0%) on Sep 23, 2026

All Ondine Biomedical, Inc. news

Financings

  • Private placement of new Common Shares

    Oct 20, 2026 · US$13.31M

    Update: £10M · £0.1 a share · Peel Hunt LLP +2

    Dealers: Peel Hunt LLP (lead), Orana Corporate LLP, Strand Hanson Limited

    Buyers: Carolyn Cross (10,593,220 Subscription Shares for approximately £1.06 million)

    Insiders: CEO Carolyn Cross subscribed for 10,593,220 Subscription Shares for about £1.06 million; other Directors subscribed for 1,141,464 Subscription Shares, about £0.11 million, through amounts owed to them

    Use of proceeds: Expand sales and business development, and advance regulatory, manufacturing and submission work for a planned NDA submission in mid-2027

    Update Oct 20, 2026

  • Common shares

    Sep 30, 2026

    Announced: raise

    Use of proceeds: Publishing full LANTERN trial analyses, FDA engagement toward a mid-2027 NDA, commercial pilots, sales and marketing, and working capital

    Announced Sep 30, 2026

Read by 6ix AI from the company's releases

Ondine Biomedical, Inc. on 6ix

News releases
44 in the last 12 months · 210 in all · newest Oct 28, 2026 · oldest 2021
Calls
9 calls with a replay · 9 with a transcript · latest Sep 10, 2026

Where Ondine Biomedical, Inc. is listed

ListingExchangeCountryCurrency
LSE:OBI · Home listing · This pageLSEUnited KingdomGBX
OTC:OBIMFOTCUnited StatesUSD
Frankfurt:VF5FrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Ondine Biomedical, Inc.